临床外科杂志 ›› 2020, Vol. 28 ›› Issue (10): 926-929.doi: 10.3969/j.issn.1005-6483.2020.10.010

• • 上一篇    下一篇

脑脊液循环重建联合去骨瓣减压术对颅脑损伤病人颅内压及缺氧诱导因子-1α、胶质纤维酸性蛋白和纤溶酶原激活物的影响

  

  1. 266000 山东省青岛市市立医院神经外科
  • 出版日期:2020-10-20 发布日期:2020-10-20
  • 通讯作者: 韩涛,Email:hantao1234@126.com

Curative efficacy of Cerebrospinal fluid circulation reconstruction combined with decompression of bone flap in treatment of Traumatic brain injuryand its effectson intracranial pressure and HIF-1,GFAP and t-pa

  1. Department of Neurosurgery,Qingdao Municipal Hospital,Shandong,Qingdao 266000,China
  • Online:2020-10-20 Published:2020-10-20

摘要: 目的  探讨脑脊液循环重建联合去骨瓣减压术对颅脑损伤病人颅内压及缺氧诱导因子(HIF)-1α、胶质纤维酸性蛋白(GFAP)和纤溶酶原激活物(t-PA)的影响。
方法  2017年6月~2019年6月在我院接受治疗的颅脑损伤病人125例,采用抽签法分为观察组(63例)和对照组(62例)。对照组给予去骨瓣减压术治疗,观察组在对照组的基础上给予脑脊液循环重建治疗。比较两组病人的临床疗效、血清HIF-1α、GFAP、t-PA、颅内压、格拉斯哥预后评分(GOS)、大脑神经功能分级(CPC)、欧洲卒中评分量表(ESS)评分变化情况及并发症发生情况。
结果  两组总有效率分别为92.06%,72.58%,差异有统计学意义(P<0.05);治疗前,两组血清HIF-1α、GFAP、t-PA水平无明显差异;治疗后,两组血清HIF-1α、GFAP、t-PA水平均显著改善,且观察组上述指标均低于对照组,差异有统计学意义(P<0.05);治疗前,两组颅内压、GOS评分水平无明显差异;治疗后,两组颅内压、GOS评分水平均显著改善,且观察组颅内压低于对照组,GOS评分高于对照组,差异有统计学意义(P<0.05);治疗前,两组CPC、ESS评分水平无明显差异;治疗后,两组CPC、ESS评分水平均显著改善,且观察CPC评分低于对照组,ESS评分高于对照组,差异有统计学意义(P<0.05);两组并发症总发生率分别为9.52%、32.26%,差异有统计学意义(P<0.05)。
结论  在颅脑损伤病人中应用脑脊液循环重建联合去骨瓣减压术效果显著,可有效改善病人颅内压及血清HIF-1α、GFAP、t-PA水平,并发症较少。

关键词: 脑脊液循环重建, 去骨瓣减压术, 颅脑损伤, 颅内压, 缺氧诱导因子-1α, 胶质纤维酸性蛋白, 纤溶酶原激活物

Abstract: Objective To study Curative efficacy of Cerebrospinal fluid circulation reconstruction combined with decompression of bone flap in treatment of Traumatic brain injuryand its effectson intracranial pressure and Hypoxia-inducible factor-1(HIF-1),glial fibrinoacidic protein(GFAP),plasminogen activator(t-PA).
Methods 125 patients with craniocerebral injury who were treated in our hospital from June 2017 to June 2019 were selected and divided into the observation group(n=63) and the control group(n=62) by lottery.The control group was treated with decompression of bone flap,and the observation group was treated with cerebrospinal fluid circulation reconstruction on the basis of the control group.The clinical efficacy,changes in serum HIF-1,GFAP,t-PA,intracranial pressure,Glasgow outcome score(GOS),cerebral nerve function scale(CPC),European stroke score scale(ESS) and complications were compared between the two groups.
Results The total effective rate of the two groups was 92.06% and 72.58%,respectively(P<0.05).Before treatment,there was no significant difference in serum HIF-1,GFAP and t-PA levels between the two groups.After treatment,serum HIF-1,GFAP and t-PA levels in both groups were significantly improved,and the above indicators in the observation group were lower than those in the control group(P<0.05).Before treatment,there was no significant difference in intracranial pressure and GOS score between the two groups.After treatment,intracranial pressure and GOS scores in both groups were significantly improved,and intracranial pressure was lower than the control group,and GOS scores were higher than the control group(P<0.05).Before treatment,there was no significant difference in CPC and ESS scores between the two groups.After treatment,CPC and ESS scores in both groups were significantly improved,and CPC scores were lower than the control group,and ESS scores were higher than the control group(P<0.05).The total incidence of complications in the two groups was 9.52% and 32.26%,with statistically significant differences(P<0.05).
Conclusion Cerebrospinal fluid circulation reconstruction combined with craniocerebral flap decompression in patients with craniocerebral injury has a significant effect,which can effectively improve patients’ intracranial pressure and serum HIF-1,GFAP,t-PA levels,and fewer complications.

Key words: cerebrospinal fluid circulation reconstruction, decompression of bone flap, head injury, intracranial pressure, hypoxia-inducible factor-1, glial fibrillary acidic protein, plasminogen activator

[1] 李政委, 王杭州, 朱炳鑫等. 学龄前儿童中重型颅脑损伤预后不良相关因素分析[J]. 临床外科杂志, 2020, 28(6): 545-547.
[2] 李静, 孙冬弢. 重度颅脑损伤病人颅内血肿清除术后急性肾功能不全的危险因素分析[J]. 临床外科杂志, 2020, 28(6): 581-583.
[3] 关俊文 孙彤 袁轶恺 杨靖国. 骨瓣的去与留[J]. 临床外科杂志, 2020, 28(10): 907-910.
[4] 江荣才. 需强调重型脑外伤病人的年龄和病程分层治疗[J]. 临床外科杂志, 2020, 28(10): 911-913.
[5] 肖仕和 李钢 周奋 刘珍 刘仲海. 血清中脑源性神经营养因子、血管内皮生长因子水平与创伤性颅脑损伤病情严重程度及预后的关系[J]. 临床外科杂志, 2020, 28(10): 982-984.
[6] 吕学文, 张小雷, 谢利娜, 杨红秀. 重症颅脑损伤病人气管切开术后继发肺部真菌感染的危险因素分析[J]. 临床外科杂志, 2019, 27(8): 700-702.
[7] 吕学文, 杨永康, 张小雷, 张亦文. 创伤性颅脑损伤患者凝血功能及炎性因子的变化研究[J]. 临床外科杂志, 2019, 27(3): 247-249.
[8] 胡均贤, 徐春林, 吴雅兰. 环池形态改变与颅脑损伤开颅术后常见并发症的关系研究[J]. 临床外科杂志, 2019, 27(2): 135-137.
[9] 张福征 王才永 沈俊岩等. 重型颅脑损伤患者早期应用肠内营养的疗效观察[J]. 临床外科杂志, 2012, 20(7): 489-490.
[10] 邓全军. 脑室内颅内压监测在颅脑手术后的临床应用[J]. 临床外科杂志, 2012, 20(4): 267-267.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 邱远;杨桦. 营养支持治疗在重症患者肠功能维护中的作用[J]. 临床外科杂志, 2016, 24(12): 889 .
[2] 沈攀;刘琳. D1和D2淋巴结清扫术治疗胃癌合并失代偿性肝硬化的效果比较[J]. 临床外科杂志, 2016, 24(12): 940 .
[3] 李旸凯;陈滔;李樊;等. pN2/Ⅲ期非小细胞肺癌五年生存期与纵隔淋巴结转移相关性的回顾性分析[J]. 临床外科杂志, 2016, 24(12): 950 .
[4] 易凡;尚玉强;夏家红;等. 重症瓣膜病患者围手术期营养支持治疗体会[J]. 临床外科杂志, 2016, 24(12): 912 .
[5] 方洪松;陈森;彭昊 . 3D打印技术在成人CroweⅣ型发育性髋关节脱位关节置换中的临床应用 [J]. 临床外科杂志, 2016, 24(6): 458 .
[6] 陈英;钟文昭. 第8版肺癌TNM分期浅析[J]. 临床外科杂志, 2016, 24(7): 486 .
[7] 傅剑华;谭子辉. 食管癌的分期策略[J]. 临床外科杂志, 2016, 24(7): 521 .
[8] 蒋米尔;黄英. 微创化和高科技时代外科治疗的进展与挑战[J]. 临床外科杂志, 2016, 24(8): 569 .
[9] 李会 李兴睿. 乳腺癌靶向治疗进展及趋势[J]. 临床外科杂志, 2016, 24(9): 656 .
[10] 王丽 刘运江 杨帆等. 过氧化物酶体增殖物激活受体γ辅激活因子1α在乳腺癌患者中的表达及其与临床病理特征关系研究[J]. 临床外科杂志, 2016, 24(9): 680 .